Global Fertility Services Market 2016-2020 - High Cost of Fertility Treatment a Key Challenge - Research and Markets

DUBLIN, April 27, 2016 /PRNewswire/ --

Research and Marketshas announced the addition of the"Global Fertility Services Market 2016-2020"report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

The global fertility services market is set to grow at a CAGR of 8.72% during the period 2016-2020.

Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.

The rising demand for fertility services will require an increase in the volume of supply. Governments of various countries are establishing new fertility clinics to manage the demand for fertility services. Vendors are conducting R&D to further improve the technology of available fertility services and develop innovative techniques.

According to the report, with aging, the human body undergoes various physiological and hormonal changes that can contribute to problems related to fertility. Medical studies by different research institutes state that women aged 35 years and above face various complications related to fertility. These studies estimate that women in this age group have an infertility rate of over 35%. Aging causes decreased sperm motility in men. The presence of obesity adds to fertility complications in both men and women. Obesity is a known cause of infertility, as it leads to problems with ovulation and low sperm count.

Further, the report states that the cost of fertility services is high in the US compared to countries such as India, Taiwan, and Hong Kong. Fertility services can lead to multiple pregnancies, internal bleeding or infection, and congenital defects. Costs related to the treatment of these complications can further increase the overall costs for people undergoing fertility services.

Key vendors:

• Carefertility
• Coopersurgical
• Ferring Pharmaceuticals
• Merck
• MonashIVF
• Vitrolife

Key questions answered in this report:

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Stages of fertility treatment

PART 07: Regulatory landscape of ART and IVF

PART 08: Fertility tourism

PART 09: Cost analysis

PART 10: Market segmentation by type of treatment

PART 11: Geographical segmentation

PART 12: Key leading countries

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

For more information visithttp://www.researchandmarkets.com/research/ltxm8w/global_fertility

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]